Skip to main content
. 2022 Dec 7;12:21116. doi: 10.1038/s41598-022-24980-2

Figure 6.

Figure 6

(A) The number of matched candidate compounds across nine cancer types using structural similarity (TC) ≥ 0.2, (B) Number of matched candidate compounds using structural similarity (TC)  ≥ 0.5, (C) Distribution of DrugRepo scores for matched compounds for structural similarity (TC)  ≥  0.2, (D) Distribution of DrugRepo scores for matched compounds for structural similarity (TC)  ≥  0.5. (E) Distribution of compound-disease score for repurposed compounds TC  ≥  0.2, (F) Distribution of compound-disease score for repurposed compounds TC  ≥  0.5, (G) Distribution overlapping target profile scores between approved and repurposed compounds TC  ≥  0.2, (H) Distribution overlapping target profile scores between approved and repurposed compounds TC  ≥  0.5.